通过调节GRP78-PI3K-AKT信号通路,RCN3作为结直肠癌中的瘤促进剂
在PubMed上查看摘要
概括
此摘要是机器生成的。在结直肠癌 (CRC) 中,甲基素-3 (RCN3) 升高调节,促进瘤生长和转移. 向RCN3可能为改善CRC患者的治疗结果提供新的治疗策略.
科学领域
- 癌症学
- 分子生物学
- 细胞生物学
背景情况
- 结肠直肠癌 (CRC) 是一个全球性的健康挑战.
- 在CRC中急需新的治疗点和预后生物标志物.
- 在癌症进展相关的细胞过程中,Reticulocalbin-3 (RCN3) 有关.
研究的目的
- 调查雷蒂库洛卡宾-3 (RCN3) 在结直肠癌 (CRC) 发展中的作用.
- 探索RCN3对CRC中的稳定和运输蛋白的调节影响.
- 评估RCN3作为CRC潜在的预后生物标志物和治疗点.
主要方法
- 生物信息学分析
- 定量的实时PCR (qRT-PCR)
- 西部涂抹
- 免疫组织化学
- 在体外和体内功能测试
主要成果
- 在CRC组织中,RCN3表达是上调的,与患者的不良结果相关.
- 改变RCN3表达显著增加CRC细胞的增殖,迁移和侵入.
- RCN3与GRP78相互作用,影响水平,内网压力和PI3K- AKT- mTOR- S6通路.
结论
- 在促进CRC进展方面,RCN3发挥着多方面的作用.
- RCN3是CRC的潜在预后生物标志物.
- RCN3是治疗结直肠癌的一个有前途的标.
相关概念视频
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Guanine nucleotide exchange factors or GEF,
GTPase-activating proteins or GAPs, and
Guanine nucleotide-dissociation inhibitors or GDIs.
The GEF activates the GTPase by exchanging the bound-GDP with GTP. The...

